We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Okyo Pharma Ltd (OKYO) Ord NPV

Sell:6.70p Buy:7.20p 0 Change: 0.30p (4.14%)
Market closed Prices as at close on 26 November 2021 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:6.70p
Buy:7.20p
Change: 0.30p (4.14%)
Market closed Prices as at close on 26 November 2021 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:6.70p
Buy:7.20p
Change: 0.30p (4.14%)
Market closed Prices as at close on 26 November 2021 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

OKYO Pharma Limited is a United Kingdome-based biopharmaceutical company. The Company’s operating segment is research and development of biotechnological and pharmaceutical products. The Company focuses on G-protein coupled receptors (GPCR) based therapeutics for eye diseases and non-opioid analgesics for chronic pain. It is developing drug candidates for the treatment of dry-eye, uveitis, ocular and chronic pain. The Company’s therapeutic approach is to develop drug candidates that target inflammatory pathways using membrane-tethered ligand technology. The Company focuses to suppress the inflammation associated with the uveitis using its anti-inflammatory compound. Its product candidates include OKYO-0101 and OHYO-0201. The OKYO-0101 is focused on uveitis and allergic conjunctivitis. The OHYO-0201 is focused on ocular pain and chronic pain. OKYO Pharma US Inc is the subsidiary of the Company.

Contact details

Address:
55 Park Lane
LONDON
W1K 1NA
United Kingdom
Telephone:
+44 (020) 74952379
Website:
okyopharma.com/

Important dates

Future events
There are no future events available.
Past events
AGM 27 September 2021 27/09/21
Annual report 02 August 2021 02/08/21
Final results 02 August 2021 02/08/21
Interim results 30 November 2020 30/11/20

General stock information

EPIC:
OKYO
ISIN:
GG00BD3FV870
Market cap:
£67.46 million
Shares in issue:
970.69 million
Sector:
No specific Industry
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
n/a

Key personnel


Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.